298 related articles for article (PubMed ID: 32543879)
1. Chemokine (C-X-C Motif) Ligand 4 Is a Restrictor of Respiratory Syncytial Virus Infection and an Indicator of Clinical Severity.
Han Z; Rao J; Xie Z; Wang C; Xu B; Qian S; Wang Y; Zhu J; Yang B; Xu F; Lei X; Guo F; Zhao Z; Ren L; Wang J
Am J Respir Crit Care Med; 2020 Sep; 202(5):717-729. PubMed ID: 32543879
[No Abstract] [Full Text] [Related]
2. Comparing Human Metapneumovirus and Respiratory Syncytial Virus: Viral Co-Detections, Genotypes and Risk Factors for Severe Disease.
Moe N; Krokstad S; Stenseng IH; Christensen A; Skanke LH; Risnes KR; Nordbø SA; Døllner H
PLoS One; 2017; 12(1):e0170200. PubMed ID: 28095451
[TBL] [Abstract][Full Text] [Related]
3. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity.
Fodha I; Vabret A; Ghedira L; Seboui H; Chouchane S; Dewar J; Gueddiche N; Trabelsi A; Boujaafar N; Freymuth F
J Med Virol; 2007 Dec; 79(12):1951-8. PubMed ID: 17935185
[TBL] [Abstract][Full Text] [Related]
5. Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
Jefferies K; Drysdale SB; Robinson H; Clutterbuck EA; Blackwell L; McGinley J; Lin GL; Galal U; Nair H; Aerssens J; Öner D; Langedijk A; Bont L; Wildenbeest JG; Martinon-Torres F; Rodríguez-Tenreiro Sánchez C; Nadel S; Openshaw P; Thwaites R; Widjojoatmodjo M; Zhang L; Nguyen TL; Giaquinto C; Giordano G; Baraldi E; Pollard AJ;
J Infect Dis; 2020 Oct; 222(Suppl 7):S658-S665. PubMed ID: 32794560
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection.
Yan XL; Li YN; Tang YJ; Xie ZP; Gao HC; Yang XM; Li YM; Liu LJ; Duan ZJ
J Med Virol; 2017 Apr; 89(4):589-597. PubMed ID: 27632796
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
[TBL] [Abstract][Full Text] [Related]
8. The alpha-1 subunit of the Na+,K+-ATPase (ATP1A1) is required for macropinocytic entry of respiratory syncytial virus (RSV) in human respiratory epithelial cells.
Lingemann M; McCarty T; Liu X; Buchholz UJ; Surman S; Martin SE; Collins PL; Munir S
PLoS Pathog; 2019 Aug; 15(8):e1007963. PubMed ID: 31381610
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell counts and interleukin-8 and CCL-5 plasma concentrations discriminate disease severity in children with RSV infection.
Brand HK; Ferwerda G; Preijers F; de Groot R; Neeleman C; Staal FJ; Warris A; Hermans PW
Pediatr Res; 2013 Feb; 73(2):187-93. PubMed ID: 23165450
[TBL] [Abstract][Full Text] [Related]
10. Clinical correlation of influenza and respiratory syncytial virus load measured by digital PCR.
Hijano DR; Brazelton de Cardenas J; Maron G; Garner CD; Ferrolino JA; Dallas RH; Gu Z; Hayden RT
PLoS One; 2019; 14(9):e0220908. PubMed ID: 31479459
[TBL] [Abstract][Full Text] [Related]
11. Effects of Alterations to the CX3C Motif and Secreted Form of Human Respiratory Syncytial Virus (RSV) G Protein on Immune Responses to a Parainfluenza Virus Vector Expressing the RSV G Protein.
Liang B; Kabatova B; Kabat J; Dorward DW; Liu X; Surman S; Liu X; Moseman AP; Buchholz UJ; Collins PL; Munir S
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651356
[TBL] [Abstract][Full Text] [Related]
12. Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1.
Pierangeli A; Viscido A; Bitossi C; Frasca F; Gentile M; Oliveto G; Frassanito A; Nenna R; Midulla F; Scagnolari C
Med Microbiol Immunol; 2020 Feb; 209(1):23-28. PubMed ID: 31485724
[TBL] [Abstract][Full Text] [Related]
13. CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.
Chirkova T; Lin S; Oomens AGP; Gaston KA; Boyoglu-Barnum S; Meng J; Stobart CC; Cotton CU; Hartert TV; Moore ML; Ziady AG; Anderson LJ
J Gen Virol; 2015 Sep; 96(9):2543-2556. PubMed ID: 26297201
[TBL] [Abstract][Full Text] [Related]
14. Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children.
Kim YI; Murphy R; Majumdar S; Harrison LG; Aitken J; DeVincenzo JP
Pediatr Res; 2015 Oct; 78(4):380-8. PubMed ID: 26107392
[TBL] [Abstract][Full Text] [Related]
15. A Druggable Pocket at the Nucleocapsid/Phosphoprotein Interaction Site of Human Respiratory Syncytial Virus.
Ouizougun-Oubari M; Pereira N; Tarus B; Galloux M; Lassoued S; Fix J; Tortorici MA; Hoos S; Baron B; England P; Desmaële D; Couvreur P; Bontems F; Rey FA; Eléouët JF; Sizun C; Slama-Schwok A; Duquerroy S
J Virol; 2015 Nov; 89(21):11129-43. PubMed ID: 26246564
[TBL] [Abstract][Full Text] [Related]
16. Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure.
Thwaites RS; Coates M; Ito K; Ghazaly M; Feather C; Abdulla F; Tunstall T; Jain P; Cass L; Rapeport G; Hansel TT; Nadel S; Openshaw P
Am J Respir Crit Care Med; 2018 Oct; 198(8):1074-1084. PubMed ID: 29688024
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
[TBL] [Abstract][Full Text] [Related]
18. Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.
Johnson SM; McNally BA; Ioannidis I; Flano E; Teng MN; Oomens AG; Walsh EE; Peeples ME
PLoS Pathog; 2015 Dec; 11(12):e1005318. PubMed ID: 26658574
[TBL] [Abstract][Full Text] [Related]
19. Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness.
Ramilo O; Lagos R; Sáez-Llorens X; Suzich J; Wang CK; Jensen KM; Harris BS; Losonsky GA; Griffin MP;
Pediatr Infect Dis J; 2014 Jul; 33(7):703-9. PubMed ID: 24356256
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease.
Baier C; Haid S; Beilken A; Behnert A; Wetzke M; Brown RJP; Schmitt C; Ebadi E; Hansen G; Schulz TF; Pietschmann T; Bange FC
Antimicrob Resist Infect Control; 2018; 7():21. PubMed ID: 29449938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
